Cornercap Investment Counsel’s Avanos Medical AVNS Stock Holding History

Cornercap Investment Counsel’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-25,769	Closed	-$410K	–	184
2024 Q4	$410K	Hold	25,769	–	–	0.13%	269
2024 Q3	$619K	Sell	25,769 -28,302	-52%	-$647K	0.18%	179
2024 Q2	$1.08M	Buy	+54,071	New	+$1.05M	0.18%	192
2023 Q4	–	Sell	-34,991	Closed	-$708K	–	587
2023 Q3	$708K	Sell	34,991 -1,169	-3%	-$26.5K	0.13%	325
2023 Q2	$924K	Sell	36,160 -5,816	-14%	-$153K	0.16%	276
2023 Q1	$1.25M	Hold	41,976	–	–	0.22%	118
2022 Q4	$1.14M	Hold	41,976	–	–	0.2%	153
2022 Q3	$914K	Buy	41,976 +5,951	+17%	+$155K	0.17%	228
2022 Q2	$985K	Buy	36,025 +427	+1%	+$12.3K	0.17%	233
2022 Q1	$1.19M	Buy	+35,598	New	+$1.15M	0.13%	212
2017 Q1	–	Sell	-16,050	Closed	-$594K	–	343
2016 Q4	$594K	Hold	16,050	–	–	0.1%	246
2016 Q3	$556K	Buy	+16,050	New	+$562K	0.1%	255
2015 Q4	–	Sell	-32,545	Closed	-$926K	–	343
2015 Q3	$926K	Buy	+32,545	New	+$1.14M	0.18%	90

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cornercap Investment Counsel's AVNS Position: Q1 2025 in Review

Cornercap Investment Counsel sold out of Avanos Medical (AVNS) in Q1 2025, closing a stake of 25,769 shares — an estimated $410K sold.

Cornercap Investment Counsel first reported a position in AVNS in Q3 2015 and held it in 13 quarters. The position peaked at $1.25M in Q1 2023. 277 funds tracked by Wall St. Rank hold AVNS as of Q1 2025.

Cornercap Investment Counsel reported no remaining Avanos Medical position as of Q1 2025 after selling out during the quarter.
Cornercap Investment Counsel sold 25,769 Avanos Medical shares in Q1 2025, an estimated $410K.
Cornercap Investment Counsel first reported a position in Avanos Medical in Q3 2015 and held it in 13 quarters.
Cornercap Investment Counsel's Avanos Medical position peaked at $1.25M in Q1 2023.
277 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2025.

Based on Cornercap Investment Counsel's 13F filing for Q1 2025, filed 2 May 2025.